India’s role in increasing access to HCV drugs
Early intervention by the Indian government and civil society will be essential to overcome patent barriers to ensure that the new drugs …
India denies Gilead patent for hepatitis C drug, sofosbuvir
Companies that have not signed any licence agreement with US pharma giant are now free to produce generic versions of the drug
Gilead expands hepatitis C licensing pacts with Indian companies
New programme introduces coercion and policing upon medical providers and may result in treatment interruptions for patients
Why Modi's razzmatazz diplomacy isn't serving African interests
Missing from Modi’s foreign trips is a focus on issues most pressing for Africa’s people
Bushmeat contributing to Ebola epidemic, warns FAO
Ebola death toll rises to over 630
TB drugs shortage: health activists to write to prime minister
Critical drugs for children and drug-resistant TB patients out of stock; may lead to increase in drug resistance cases
Drought impact: Acute malnutrition among children rises 40% in Somalia & Somaliland
Families in Somalia taking extreme measures to survive
WHO’s Ebola vaccination strategy ineffective in DRC: MSF
The aid agency has also called for an independent, international committee to manage Ebola vaccine stocks and their use
Effective oral drug for Hepatitis C approved by European agencies
Various patent barriers hinder its availability and affordability, especially in countries with high burden of disease
Medicines Pool Swirls
Drug companies are slowly joining the UN effort to offer life-saving patented medicines to poor countries but the terms are sometimes restrictive
Cost of vaccination has risen 68 times in a decade, says report
Crisis looms as donor withdraws support to African countries; MSF urges GSK, Pfizer to slash vaccine price
Treating malnourished children at home yields better results, says study
Since uncomplicated cases do not need admission in rehabilitation centres, parents do not miss out on wages
Bedaquiline to be used in TB treatment, but with caution
Final phase trials of drug pending; World Health Organization issues guidelines on interim use
Activists demand compulsory licence for another life-saving cancer drug
Appellate board's order upholding Natco's CL for sorafenib tosylate may pave way for manufacture of generic version of other patented drugs
Drug-resistant TB now epidemic among HIV+ people in Mumbai
Transmission from one person to another, not inadequate treatment, is major cause for spread of disease, says study investigator
World Hepatitis Day: Who can pay for hepatitis C treatment?
Selling price of HCV drugs far higher than production cost, all because of pro-industry patent regime
Getting the drug equation right
Sonal Matharu reports how fights over counterfeit drugs and low-quality drugs is suppressing the larger issue of drug safety
European Parliament rejects Anti-Counterfeiting Trade Agreement
Act makes it possible to seize and destroy even legitimately produced generic drugs exported from India to poor countries
US keeps India out of Priority Foreign Country list of 'worst IP offenders'
US Trade Representative’s Special 301 Report keeps up pressure on India to fall in line with US’ interests
On WHO agenda: a global vaccine action plan
Health activists say new policy may not address the weaknesses in ongoing routine immunisation programmes and would flood poor countries with new …
Any cheers for Doha pact?
The Doha Declaration on protecting public health is a decade old, but developing countries have not been able to make use of TRIPs flexibilities
Deadly Ebola fever in West Africa spreads panic
135 people have died of it so far; scientists declare a new strain of Ebola virus is behind the epidemic
Sub-standard drugs bigger problem than counterfeit drugs: health activists
Problem of poor quality drugs cannot be solved with technology alone, they say
Will appellate body uphold grant of compulsory licence to cancer drug?
Hearing on Bayer's appeal against manufacture of generic version of Nexavar to conclude this week
Indian company gets licence to manufacture and sell patented cancer drug
This is the first-ever compulsory licence given to a generic drug company